2003
DOI: 10.1016/s0022-510x(03)00104-7
|View full text |Cite
|
Sign up to set email alerts
|

Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

35
328
4
6

Year Published

2007
2007
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 379 publications
(373 citation statements)
references
References 25 publications
35
328
4
6
Order By: Relevance
“…Taken together, the presence of axial bradykinesia likely represents a key element of MPS responsible for abnormal gait performance in normal aging. In addition, the similarity of the present investigation, linking bradykinesia and quantitative gait parameters, with previous PD studies (Morris et al 1994;Schaafsma et al 2003) suggests a deficit in the nigral pathway. In support, a recent clinicopathological study reported that nigral neuronal loss was associated with the presence of MPS in aging (Buchman et al 2012).…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Taken together, the presence of axial bradykinesia likely represents a key element of MPS responsible for abnormal gait performance in normal aging. In addition, the similarity of the present investigation, linking bradykinesia and quantitative gait parameters, with previous PD studies (Morris et al 1994;Schaafsma et al 2003) suggests a deficit in the nigral pathway. In support, a recent clinicopathological study reported that nigral neuronal loss was associated with the presence of MPS in aging (Buchman et al 2012).…”
Section: Discussionsupporting
confidence: 90%
“…Furthermore, bradykinesia has been associated with stride time variability during "on" but not "off" state," which suggests an association with levodopa integrity (Schaafsma et al 2003). Concerning the dopaminergic pathway, both bradykinesia and PIGD have been associated with [ 123 I]β-CIT SPECT binding in patients with PD (Pirker 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Participants were tested under the following conditions: 1) Baseline: (usual walking for 100 meters); 2) RAS set to each participant's normal cadence; 3) Usual walking (to assess any carryover effect); 4) RAS set to 110% of usual cadence; 5) Usual walking (to assess immediate carryover effect); and 6) Usual walking 15 min later (to assess longer carryover). As in previous studies (Blin et al, 1990;Hausdorff et al, 1998;Hausdorff et al, 2000;Schaafsma et al, 2003), both stride time variability and swing time variability were significantly increased in the participants with PD compared to the controls under usual walking conditions (p < .01). When RAS was set to each participant's usual cadence, the variability of the stride time and swing time tended to decrease among the participants with PD, but the effect was not significant.…”
Section: Rhythmic Auditory Stimulation (Ras) Improves Gait Rhythmicitsupporting
confidence: 83%
“…In general, however, the relationships between gait variability, fall risk, and other parkinsonian features were not wellstudied and the effect of levodopa on falls and gait variability were also largely unknown. To better understand the effects of PD on walking, especially gait instability, and the factors that contribute to gait variability and fall risk in PD, we studied patients with idiopathic PD in order to evaluate: (1) the relationship between gait variability, fall history and other parkinsonian features, and (2) the effect of levodopa on gait variability and fall frequency (Schaafsma et al, 2003). Forty-one percent of these patients reported a history of falls.…”
Section: Gait Variability and Fall Risk In Parkinson's Disease (Pd)mentioning
confidence: 99%
See 1 more Smart Citation